ENTITY
Takara Bio Inc

Takara Bio Inc (4974 JP)

53
Analysis
Health Care • Japan
TAKARA BIO INC. is a biopharmaceutical company. The Company researches and develops reagents for genome engineering and analysis, technology used for gene therapy, and natural health food products using mushrooms and seaweed body and extracts.
more
•15 Feb 2026 15:34

Weekly Deals Digest (15 Feb) - Hisamitsu, Takara Bio, Toyota Ind, Mandom, Dongfeng, Pepper Money

A weekly summary of key developments across ECM and Event-Driven names tracked by us across Hong Kong, Australia, NZ, Singapore, Japan, Indonesia,...

Logo
293 Views
Share
bullish•Ana Holdings
•27 Feb 2025 15:46

Quiddity JPX-Nikkei 400 Rebal 2025: End-Feb 2025 Ranks

There are 45 Potential ADDs and 44 Potential DELs (unique names) presented in the current Quiddity Leaderboard. The High and Medium conviction ADDs...

Share
bearish•Takara Bio Inc
•22 Feb 2024 09:30

Takara Bio (4974 JP): Limited Upside Potential Amid Poor Financial Result and Bleak Outlook

​Takara Bio reports massive declines in sales and profit in 9MFY24, due to decrease of sales of COVID testing reagents. Company anticipates...

Logo
459 Views
Share
bullish•Pasona Group
•19 Nov 2023 07:05

Last Week in Event SPACE: Zhejiang, Pasona, ENN Energy, Asahi Group, Azure Minerals

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
735 Views
Share
bearish•Takara Bio Inc
•16 Nov 2023 22:39

Takara Bio (4974 JP): Smaller-Than-Expected Decline in H1FY24 Profit; FY24 Guidance Revised Downward

Takara Bio has cut FY24 sales, operating profit, and net profit guidance by 15%, 63%, and 64%, respectively due to anticipated sluggish life...

Logo
662 Views
Share
x